SMTL ID : 3wbl.1

Crystal structure of CDK2 in complex with pyrazolopyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 3 residues within 4Å: Chain A: E.257, R.260, S.261 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.260

1 x PDY: N~7~-(4-ethoxyphenyl)-6-methyl-N~5~-[(3S)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidine-5,7-diamine(Non-covalent)

PDY.2: 15 residues within 4Å: Chain A: I.10, G.13, V.18, A.31, K.33, E.81, F.82, L.83, H.84, Q.85, D.86, Q.131, N.132, L.134, D.145 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:A.31, A:L.134, A:L.134 Hydrogen bonds: A:L.83, A:L.83, A:N.132

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fujino, A. et al., Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity. J.SYNCHROTRON RADIAT. (2013)

Release Date

2013-10-30

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence